STOCK WATCH

SHARES in Feedback spiked after it inked a software licence and distribution agreement with General Electric Healthcare.

The deal gives GE the global rights to distribute Feedback’s medical imaging analysis software, Texrad, with India first on the list.

Used by 40 research institutions worldwide, it allows researchers to analyse the textures in radiological scans to detect the presence of cancer. Shares rocketed 71.2pc, or 1.3p, to 3.15p.